(Q41276422)

29 September 2017

Metastatic Renal Cell Cancer and Radical Nephrectomy: Identification of Prognostic Factors and Patient Survival (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

3 January 2023

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

3 January 2023

author name string

R. J. Neves

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3373580

3 January 2023

H. Zincke

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3373580

3 January 2023

W. F. Taylor

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3373580

3 January 2023

language of work or name

English

0 references

publication date

1 June 1988

1 reference

full work available at URL

29 September 2017

https://api.elsevier.com/content/article/PII:S0022534717428515?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

https://api.elsevier.com/content/article/PII:S0022534717428515?httpAccept=text/plain

3 January 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2817%2942851-5

3 January 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

3 January 2023

1 reference

29 September 2017

139

1 reference

29 September 2017

6

1 reference

29 September 2017

1173-1176

1 reference

Proceedings: Cancer of the kidney--natural history and staging

29 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

Renal cell carcinoma.Natural history and results of treatment

3 January 2023

2

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

Prognosis in renal carcinoma

3 January 2023

3

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

Renal cell carcinoma: long-term survival and late recurrence

3 January 2023

4

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

Aggressive versus conservative management of stage IV renal cell carcinoma

3 January 2023

6

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

The natural history of metastatic renal cell carcinoma: a computer analysis

3 January 2023

7

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

Surgery for Metastatic Renal Cell Carcinoma

3 January 2023

8

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

Is Nephrectomy Justified in Patients with Metastatic Renal Carcinoma?

3 January 2023

10

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

Angioinfarction plus nephrectomy for metastatic renal cell carcinoma--an update

3 January 2023

11

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

Active specific immunotherapy of advanced renal-cell carcinoma

3 January 2023

12

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

Immunotherapy for malignant lesions in man using immunogenic ribonucleic acid

3 January 2023

13

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

Bacillus Calmette-Guerin in the Treatment of Adenocarcinoma of the Kidney

3 January 2023

14

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

Treatment of Advanced Renal Cell Carcinoma—Traditional Methods and Innovative Approaches

3 January 2023

15

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

Proceedings: Chemotherapy of adenocarcinoma of the kidney

3 January 2023

16

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

Proceedings: Hormone-induced and spontaneous regression of metastatic renal cancer.

3 January 2023

17

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

3 January 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

Renal cell carcinoma and the clonogenic assay

3 January 2023

21

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

The treatment of renal cell carcinoma with solitary metastasis

3 January 2023

22

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)42851-5

3 January 2023

Identifiers

0 references

1 reference